Kwai Han Yoo
Hematology Kwai Han Yoo Favorite Doctor
  • SpecialtyLymphoma, acute lymphoblastic leukemia, myeloproliferative neoplasms, coagulation disorder
  • Site YouTube
      YouTube
      YouTube
Appointment
Schedule
의료진 진료일정
Week M T W T F S
AM   Present   Present    
PM   Present     Present  
Clinical Interests

Lymphoma
Acute lymphoblastic leukemia
Myeloproliferative neoplasms
Coagulation disorder
Critical care for hematologic malignancies

Education
Education
2019 Gachon University Graduate College of Medicine, Ph.D.
2016 Sungkyunkwan University Graduate College of Medicine, M.S
2009 Soonchunhyang University College of Medicine, MD
Career
Career
2018 Department of Hematology, Gachon Unviersity Gil Medical Center, Assistant Professor
2017 Department of Hematology, Gachon Unviersity Gil Medical Center, Clinical Assistant Professor
2015~2016 Department of Hematology and Oncology/Critical Care Medicine, Samsung Medical Center, Clinical Instructor
2011 Department of Internal Medicine, Samsung Medical Center, Resident
2010 Samsung Medical Center, Intern
More
Community
Community
American Society of Hematology, International Member
More
Training
Training
License
License
Hematology Oncology, Specialist
Internal Medicine, Specialist
Medical License
Kwai Han Yoo
Paper
Paper
2022 Yoo KH, Yoon DH, Kang HJ, Lee WS, Kim K, Kim JS, et al. Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features. Curr Probl Cancer. 2022;46(1):100788.
2022 Yoo KH. Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT. Blood Res. 2022;57(S1):75-8.
2022 Yi JH, Jeong SH, Kim SJ, Yoon DH, Kang HJ, Koh Y, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer research and treatment : official journal of Korean Cancer Association. 2022.
2021 Yi JH, Lee GW, Lee JH, Yoo KH, Jung CW, Kim DS, et al. Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea. Blood Res. 2021;56(4):243-51.
2021 Yoo KH, Kim HJ, Min YH, Hong DS, Lee WS, Kim HJ, et al. Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry. PLoS One. 2021;16(5):e0251011.
2021 Kim H, Kim ST, Yoo KH, Hong JY, Park YS, Lim HY, et al. ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy. In Vivo. 2021;35(1):499-505.
2020 Yoo KH, Cho J, Han B, Kim SH, Shin DY, Hong J, et al. Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults. PLoS One. 2020;15(8):e0235503.
2020 Jo JC, Kim SJ, Lee HS, Eom HS, Lee SI, Park Y, et al. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report. Annals of hematology. 2020;99(2):223-8.
2019 Yoo KH, Lee SJ, Cho J, Lee KH, Park KU, Kim KH, et al. A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13. Cancer Res Treat. 2019;51(2):718-26.
2019 Kwon S, Yoo KH, Sym SJ, Khang D. Mesenchymal stem cell therapy assisted by nanotechnology: a possible combinational treatment for brain tumor and central nerve regeneration. Int J Nanomedicine. 2019;14:5925-42.
2019 Kwoun WJ, Ahn JY, Park PW, Seo YH, Kim KH, Seo JY, et al. How useful is bone marrow study as an initial investigative tool without lymph node biopsy in malignant lymphoma?: Eleven years of experience at a single institution. J Clin Lab Anal. 2019;33(4):e22841.
2018 Yoo KH, Lee H, Suh C. Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial. Int J Hematol. 2018;107(4):395-404.
2018 Yoo KH, Kang D, Kim IR, Choi EK, Kim JS, Yoon SS, et al. Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study. Bone Marrow Transplant. 2018;53(8):967-76.
2018 Cho J, Kim SJ, Park S, Yoo KH, Ki CS, Ko Y, et al. Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma. Ann Hematol. 2018;97(8):1427-36.
2017 Kim C, Yoo KH, Kim MH, Chon HJ, Lee SI, Lee HJ, et al. Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma. Apmis. 2017;125(3):223-9.
2016 Yoo KH, Kim NK, Kwon WI, Lee C, Kim SY, Jang J, et al. Genomic Alterations in Biliary Tract Cancer Using Targeted Sequencing. Transl Oncol. 2016;9(3):173-8.
2106 Tay CK, Yoo KH, Cho YH. Intraaortic Balloon Pulsation in Peripheral Venoarterial Extracorporeal Membrane Oxygenation: More Is Not Always Better. Crit Care Med. 2016;44(12):e1251.
2016 Song HN, Jung KS, Yoo KH, Cho J, Lee JY, Lim SH, et al. Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non-Small Cell Lung Cancer. J Thorac Oncol. 2016;11(4):e45-7.
2016 Lee K, Kwon HJ, Kim IY, Yoo KH, Lee S, Min YW, et al. Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain. Gut Liver. 2016;10(1):152-5.
2016 Lee JY, Sun JM, Lim SH, Kim HS, Yoo KH, Jung KS, et al. A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib. Clin Cancer Res. 2016;22(9):2139-45.
2016 Lee JY, Lee I, Chang WJ, Ahn SM, Lim SH, Kim HS, et al. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis. Oncotarget. 2016;7(28):43492-503.
2016 Kim HK, Ham JS, Byeon S, Yoo KH, Jung KS, Song HN, et al. Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea. Cancer Res Treat. 2016;48(4):1382-8.
2016 Choi JW, Kong DS, Seol HJ, Nam DH, Yoo KH, Sun JM, et al. Outcomes of Gamma Knife Radiosurgery in Combination with Crizotinib for Patients with Brain Metastasis from Non-Small Cell Lung Cancer. World Neurosurg. 2016;95:399-405.
2016 Cho J, Ahn S, Yoo KH, Kim JH, Choi SH, Jang KT, et al. Treatment outcome of PD-1 immune checkpoint inhibitor in Asian metastatic melanoma patients: correlative analysis with PD-L1 immunohistochemistry. Invest New Drugs. 2016;34(6):677-84.
2015 Yoo KH, Lee JY, Lim SH, Ko YH, Kim SJ, Kim WS. Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphoma. Acta Haematol. 2015;133(2):179-82.
2015 Yoo KH, Kim HS, Lee SJ, Park SH, Kim SJ, Kim SH, et al. Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: a retrospective case series. BMC Cancer. 2015;15:154.
2015 Lee JY, Park K, Lim SH, Kim HS, Yoo KH, Jung KS, et al. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget. 2015;6(41):43731-42.
2015 Kwon HJ, Yoo KH, Kim IY, Lee S, Jang HR, Kwon GY. Megalocytic interstitial nephritis following acute pyelonephritis with Escherichia coli bacteremia: a case report. J Korean Med Sci. 2015;30(1):110-4.
2014 Lee K, Park SJ, Kwon HJ, Kim IY, Yoo KH, Lee S, et al. Progressive increase in peridevice leakage after the implantation of the watchman device on long-term serial echocardiographic follow-up. Can J Cardiol. 2014;30(11):1461.e15-7.
More